PATENT CLAIM ANALYSIS

Application Number: 15760769
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "182000"]

Abstract:
The present invention relates to methods of accelerating, promoting or increasing hepatic regeneration, or increasing liver mass in a subject, by using a compound of formula (A): or a pharmaceutically acceptable salt thereof, and wherein R1, R2, R3, R4, R5, R6, m, and n are as described herein.

Claim (Index 16):
The method of  claim 11 , wherein the reduced liver function is the result of a disease or pathological condition selected from cerebrotendinous xanthomatosis (CTX), primary sclerosing cholangitis (PSC), drug induced cholestasis, intrahepatic cholestasis of pregnancy, parenteral nutrition associated cholestasis (PNAC), bacterial overgrowth or sepsis associated cholestasis, autoimmune hepatitis, chronic viral hepatitis, alcoholic liver disease, liver transplant associated graft versus host disease, congenital hepatic fibrosis, choledocholithiasis, granulomatous liver disease, Sjogren's syndrome, sarcoidosis, Wilson's disease, Gaucher's disease, hemochromatosis, and alpha 1-antitrypsin deficiency.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.36957
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13082261', '11819517', '14743295', '15263033', '14012401']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7811059772201195
- 35 USC 102 Novelty (BERT): 0.511901580451096
- Combined Prediction Score: 0.7541855375432173
- Mean Citation Score: 255.232656
- Max Citation Score: 266.6975
- Similarity Product: 175.8719958022237

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test